ABSTRACT
Estrogen receptor levels have been assayed in breast cancer patients. A significant increase in receptor-negative tumors was found in Kazakh menopausal women. The proportion of receptor-positive tumors correlated inversely with tumor progression, irrespective of ethnicity. A significant rise in the incidence of receptor-negative tumors was recorded in Kazakh females with breast cancer stage III.
Subject(s)
Breast Neoplasms/metabolism , Receptors, Estrogen/metabolism , Breast Neoplasms/epidemiology , Disease Progression , Female , Humans , Incidence , Kazakhstan/epidemiology , PostmenopauseABSTRACT
Functional status of the adrenal cortex was studied in 80 patients (aged 31-70) suffering esophageal cancer (predominantly stage III). Blood serum showed high levels of cortisol and 11-HCS and a decrease in those of 17-HCS and 17-KS. Groups with hypo-, normo- and hypercholesterolemia were formed. Lowered blood-cholesterol levels were more frequent in cancer patients as compared to healthy subjects. Cases under study revealed decreased immunologic vigor. A peak concentration of cortisol was matched by a decrease in E-RFC level and a sharp drop in that of blood serum cholesterol. Combined chemoradiation treatment partially brought glucocorticoid and 17-KS levels to normal but did not affect cell-mediated immunity. Complex immunocorrection and chemoradiation treatment normalized hormonal function and immunologic indexes.
Subject(s)
Adrenal Cortex/physiopathology , Cholesterol/blood , Esophageal Neoplasms/physiopathology , 11-Hydroxycorticosteroids/blood , 17-Hydroxycorticosteroids/urine , 17-Ketosteroids/urine , Adult , Aged , Combined Modality Therapy , Esophageal Neoplasms/blood , Esophageal Neoplasms/immunology , Esophageal Neoplasms/therapy , Humans , Hydrocortisone/blood , Immunity, Cellular , Male , Middle Aged , Rosette FormationABSTRACT
A radioimmunologic assay of steroid and tropic hormones levels in blood serum was carried out in 30 breast cancer patients receiving tamoxifen. Long-term treatment with tamoxifen was followed by a significant decrease in blood-estradiol, progesterone, testosterone and prolactin levels whereas FSH, LH and hydrocortisone concentrations remained virtually unchanged.